|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4866034A
(en)
|
1982-05-26 |
1989-09-12 |
Ribi Immunochem Research Inc. |
Refined detoxified endotoxin
|
|
US4987237A
(en)
|
1983-08-26 |
1991-01-22 |
Ribi Immunochem Research, Inc. |
Derivatives of monophosphoryl lipid A
|
|
US4877611A
(en)
|
1986-04-15 |
1989-10-31 |
Ribi Immunochem Research Inc. |
Vaccine containing tumor antigens and adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
JPH0655749B2
(ja)
|
1989-09-20 |
1994-07-27 |
日本たばこ産業株式会社 |
リピッドａ単糖類縁体
|
|
US5370872A
(en)
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
|
US5593969A
(en)
|
1991-09-03 |
1997-01-14 |
Igen Incorporated |
Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors
|
|
CA2138997C
(en)
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
CN1326564C
(zh)
|
1997-04-01 |
2007-07-18 |
科里克萨有限公司 |
单磷酰基脂质a的水性免疫佐剂组合物
|
|
US6500434B1
(en)
|
1998-04-23 |
2002-12-31 |
Medimmune, Inc. |
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
|
|
US6858211B1
(en)
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
KR100629028B1
(ko)
|
1998-10-16 |
2006-09-26 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
애쥬번트 시스템 및 백신
|
|
WO2001025254A2
(en)
|
1999-10-04 |
2001-04-12 |
University Of Maryland Biotechnology Institute |
Novel adjuvant comprising a lipopolysaccharide antagonist
|
|
ES2309064T3
(es)
|
2000-04-13 |
2008-12-16 |
Corixa Corporation |
Composiciones inmunoestimulantes que comprenden un fosfato de aminoalquil glucosaminida y qs-21.
|
|
AU2001271907A1
(en)
|
2000-07-07 |
2002-01-21 |
Medimmune, Inc. |
FimH adhesin proteins and methods of use
|
|
WO2002015928A1
(en)
|
2000-08-18 |
2002-02-28 |
Medimmune, Inc. |
METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS
|
|
US20030199071A1
(en)
*
|
2000-12-08 |
2003-10-23 |
Solomon Langermann |
Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
|
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
CN103285392A
(zh)
|
2005-04-26 |
2013-09-11 |
卫材R&D管理株式会社 |
用于癌症免疫疗法的组合物和其用途
|
|
ES2353814T3
(es)
|
2005-05-11 |
2011-03-07 |
Eth Zuerich |
Proteinas n-glicosiladas recombinantes de celulas procariotas.
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US8063063B2
(en)
|
2006-03-23 |
2011-11-22 |
Novartis Ag |
Immunopotentiating compounds
|
|
ES2536426T3
(es)
|
2006-03-23 |
2015-05-25 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores
|
|
CN101983070B
(zh)
|
2008-02-20 |
2016-03-30 |
格林考瓦因有限公司 |
由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
|
PE20160080A1
(es)
|
2013-05-18 |
2016-02-21 |
Aduro Biotech Inc |
Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
|
|
US20150086592A1
(en)
|
2013-09-25 |
2015-03-26 |
Sequoia Sciences, Inc |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9415101B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9149521B2
(en)
|
2013-09-25 |
2015-10-06 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9504743B2
(en)
|
2013-09-25 |
2016-11-29 |
Sequoia Sciences, Inc |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9149522B2
(en)
*
|
2013-09-25 |
2015-10-06 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9415097B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
WO2015124769A1
(en)
|
2014-02-24 |
2015-08-27 |
Glycovaxyn Ag |
Novel polysaccharide and uses thereof
|
|
WO2016183501A1
(en)
*
|
2015-05-13 |
2016-11-17 |
University Of Washington |
Compositions and methods for treatment and prevention of uropathogenic e. coli infection
|
|
EA039065B1
(ru)
|
2015-07-07 |
2021-11-29 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцина против rsv
|
|
TWI715617B
(zh)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
|
|
WO2019175147A1
(en)
|
2018-03-12 |
2019-09-19 |
Janssen Vaccines & Prevention B.V. |
Vaccines against intra-abdominal infections
|
|
US20240027467A1
(en)
|
2019-12-20 |
2024-01-25 |
Vib Vzw |
Nanobody Exchange Chromatography
|
|
EP4461744A3
(en)
|
2020-01-16 |
2025-01-08 |
Janssen Pharmaceuticals, Inc. |
Fimh mutant, compositions therewith and use thereof
|
|
KR20250007029A
(ko)
|
2021-01-12 |
2025-01-13 |
얀센 파마슈티칼즈, 인코포레이티드 |
FimH 돌연변이체, 이를 포함하는 조성물 및 이의 용도
|